Philippe Colucci

Pharmacokinetic Equivalence of a Levothyroxine Sodium Soft Capsule Manufactured Using the New Food and Drug Administration Potency Guidelines in Healthy Volunteers Under Fasting Conditions

Philippe Colucci, Pina D’Angelo, Giuseppe Mautone et al. · Therapeutic Drug Monitoring · 2011 · 44 citations

A Phase II study of intravenous exatecan mesylate (DX‐8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma

Francisco J. Esteva, Edgardo Rivera, Massimo Cristofanilli et al. · Cancer · 2003 · 33 citations

Rethinking bioequivalence and equivalence requirements of orally inhaled drug products

Dina Al-Numani, Philippe Colucci, Murray P. Ducharme · Asian Journal of Pharmaceutical Sciences · 2015 · 17 citations · Full text

Asthma, Translational Medicine, Local Action +12

Multiple-Dose Pharmacokinetic Behavior of Elvucitabine, a Nucleoside Reverse Transcriptase Inhibitor, Administered over 21 Days with Lopinavir-Ritonavir in Human Immunodeficiency Virus Type 1-Infected Subjects

Philippe Colucci, John C. Pottage, H. Robison et al. · Antimicrobial Agents and Chemotherapy · 2008 · 13 citations · Full text

Pharmacological Study, Physiologically-based Pharmacokinetic Modeling, Human Retrovirus +15

Effect of a Single Dose of Ritonavir on the Pharmacokinetic Behavior of Elvucitabine, a Nucleoside Reverse Transcriptase Inhibitor, Administered in Healthy Volunteers

Philippe Colucci, John C. Pottage, H. Robison et al. · Antimicrobial Agents and Chemotherapy · 2008 · 10 citations · Full text

Healthy Subjects, Pharmacotherapy, Experimental Pharmacology +17